Skip to main content
PREVIEW · SAMPLE DATA
This is the KOAN dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for KOAN.

KOAN

Resonate Blends, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$186.82 sample
-0.20 (-0.11%) 1D
☆ Watch
Market cap
$332.0B
Price as of
2026-10-15
Latest filing
8-K · 2026-09-03
Alerts
8
Price$186.82 +0.19% 3M daily closessample
197.55177.46
2026-07-202026-08-112026-09-022026-09-232026-10-15
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 07INSInsider sell: 10% owner
  • Sep 30INSInsider buy: Chief Executive Officer
  • Sep 23INSInsider sell: General Counsel
  • Sep 15INSInsider sell: General Counsel
  • Sep 09INSInsider buy: Chief Financial Officer
  • Sep 03SEC8-K filed: material event
  • Aug 31SEC8-K filed: material event
  • Aug 25INSInsider sell: Chief Executive Officer
Sign up to see the real KOAN record →

Company facts

SEC EDGAR registration
Name
Resonate Blends, Inc.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Smart-money score
+3sample, -100 to +100
Reporting currency
USD

Who is positioning in KOAN

sample
Insiders
18 insider transactions over 90 days, net selling, $570.8M
Congress
1 members traded over 90 days
Institutions · 13F
14 funds hold $5.1B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$9.6B +9.8% y/y
Q4 2024Q3 2026
Inventory$6.0B +10.9% y/y
Q4 2024Q3 2026
Accounts receivable$4.6B +16.3% y/y
Q4 2024Q3 2026
Total debt$12.0B +10.2% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$305.9B -8.8% 3M
Sample peer B
$256.1B +7.8% 3M
Sample peer C
$136.8B -11.4% 3M
Sample peer D
$111.8B +10.9% 3M
Sample peer E
$323.6B +1.4% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not KOAN's real figure. Nothing here is investment advice.